Skip to content

Advertisement

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony-stimulating factor (filgrastim) – a prospective, placebo-controlled, double-blind study

  • Kirsi-Maija Kaukonen1, 2Email author,
  • Heiko Herwald3,
  • Lennart Lindbom4 and
  • Ville Pettila1, 5
BMC Infectious Diseases201313:51

https://doi.org/10.1186/1471-2334-13-51

Received: 28 August 2012

Accepted: 28 January 2013

Published: 30 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Aug 2012 Submitted Original manuscript
31 Aug 2012 Author responded Author comments - Kirsi-Maija Kaukonen
Resubmission - Version 2
31 Aug 2012 Submitted Manuscript version 2
26 Oct 2012 Author responded Author comments - Kirsi-Maija Kaukonen
Resubmission - Version 3
26 Oct 2012 Submitted Manuscript version 3
3 Dec 2012 Reviewed Reviewer Report - Veronqiue Witko-Sarsat
14 Dec 2012 Reviewed Reviewer Report - Tomas Skacel
9 Jan 2013 Author responded Author comments - Kirsi-Maija Kaukonen
Resubmission - Version 4
9 Jan 2013 Submitted Manuscript version 4
Publishing
28 Jan 2013 Editorially accepted
30 Jan 2013 Article published 10.1186/1471-2334-13-51

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Intensive Care Unit, Helsinki University Central Hospital, Helsinki, Finland
(2)
ANZIC Research Centre, Department of Epidemiology and Preventative Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
(3)
Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden
(4)
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
(5)
Department of Clinical Sciences, University of Helsinki, Helsinki, Finland

Advertisement